Stock Analysts

Optimer’s Dificlir Backed in EU (CBST) (OPTR) (VPHM)

Optimer Pharmaceuticals, Inc . ( OPTR ) and partner Astellas Pharma recently announced that their antibiotic Dificlir received a positive recommendation for approval in the European Union (EU). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended approving Dificlir in the EU for the treatment of clostridium difficile-associated diarrhea (CDAD) also known as clostridium difficile infection (CDI). […]

Stock Analysts

Life, Quidel Tie Up in Europe (ILMN) (LIFE) (QDEL) (TMO)

Life Technologies Corporation ( LIFE ) recently signed an agreement with Quidel Corporation ( QDEL ) to distribute and commercialize the latter’s molecular diagnostic assays in Europe. Financial terms of the deal were not disclosed. According to Kim Caple, the head of molecular diagnostics at Life Technologies, the company currently derives 10% of revenues from molecular diagnostics, which is expected to increase in the next few years […]

Stock Analysts

AES Subsidiary To Issue Notes (AEE) (AES) (D) (DPL)

The AES Corporation ( AES ) announced that it would issue $1.25 billion worth of senior notes in a private offering by its newly formed, wholly-owned special purpose indirect subsidiary, Dolphin Subsidiary II, Inc. The private offering of senior notes consists of $450 million in aggregate principal amount with a coupon rate of 6.50% due 2016 and senior notes worth $800 million in aggregate principal amount with a coupon rate of 7.25% due 2021. The offering is expected to close on October 3, 2011. […]